Concepedia
4
Publications
211
Citations
H-Index
2021
Active since
Affiliations
Novartis (Germany)(Current)
Charité - Universitätsmedizin Berlin
Novartis (Switzerland)
Marc Ehrlich is an author at Novartis (Germany).
Publications per year
2021–2022
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial
Uwe Reuter, Marc Ehrlich, Astrid Gendolla et al. · Cephalalgia · 2021 · 157 citations · Full text
Erenumab Versus Topiramate for the Prevention of Migraine – A Randomised, Double-Blind, Active-Controlled Phase 4 Trial
Uwe Reuter, Marc Ehrlich, Astrid Gendolla et al. · SSRN Electronic Journal · 2021 · 20 citations · Full text
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
Marc Ehrlich, Christian Hentschke, Christian Sieder et al. · The Journal of Headache and Pain · 2022 · 18 citations · Full text
Results of the gErman migraine PatIent Survey on medical Care and prOPhylactic treatment Experience (EPISCOPE)
Marie Groth, Zaza Katsarava, Marc Ehrlich · Scientific Reports · 2022 · 16 citations · Full text
Rows per page
1–4 of 4